🔎 Trials Near Me

Dachaigh › Scleroderma › Pennsylvania › Pittsburgh

Sgrùdaidhean clionaigeach Scleroderma ann an Pittsburgh, PA

Tha 5 sgrùdaidhean airson Scleroderma a’ lorg phàirtichean aig làraichean ann agus timcheall air Pittsburgh (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

A’ fastadhÌre 1
  • UPMC Hillman Cancer Center, Pittsburgh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT03816345

A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

A’ fastadhÌre 2/3
  • GSK Investigational Site, Pittsburgh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 8 Sult 2026 · NCT05878717

Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis

A’ fastadhÌre 2
  • Children's Hospital of Pittsburgh of UPMC, Pittsburgh
  • University of Pittsburgh Medical Center, Pittsburgh
  • University of Pittsburgh Medical Center, Pittsburgh
Aoisean 8 gu 60 · Gach gnè · Air ùrachadh 14 Lùna 2026 · NCT03630211

Intralesional Injection of STS in Treatment of Calcinosis

A’ fastadhÌre 2
  • UPMC Arthritis and Autoimmunity Center, Pittsburgh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Cèit 2026 · NCT06672822

The Apollo Device in Systemic Sclerosis for the Management of fatiguE, Raynaud Phenomenon and qualiTy of Life

A’ fastadh
  • University of Pittsburgh and UPMC Scleroderma Center, Pittsburgh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 8 Faoi 2026 · NCT06675344

Sgrùdaidhean Scleroderma ann am bailtean eile

Sgrùdaidhean eile ann an Pittsburgh

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.